VCM
ABCL icon

Voleon Capital Management’s AbCellera Biologics ABCL Stock Holding History

Voleon Capital Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Sell
122,547
-142,778
-54% -$514K 0.01% 602
2025
Q4 		$907K Buy
265,325
+254,125
+2,269% +$1.13M 0.02% 460
2025
Q3 		$56.3K Buy
+11,200
New +$49.4K ﹤0.01% 869

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voleon Capital Management's ABCL Position: Q1 2026 in Review

Voleon Capital Management reduced its AbCellera Biologics (ABCL) stake by 54% in Q1 2026, selling an estimated $514K and leaving 122,547 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #602.

Voleon Capital Management first reported a position in ABCL in Q3 2025 and has held it in 3 quarters since. The position peaked at $907K in Q4 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Voleon Capital Management held 122,547 shares of AbCellera Biologics worth $428K as of Q1 2026.
  • Voleon Capital Management sold 142,778 AbCellera Biologics shares in Q1 2026, an estimated $514K.
  • AbCellera Biologics made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #602 holding.
  • Voleon Capital Management first reported a position in AbCellera Biologics in Q3 2025 and has held it in 3 quarters since.
  • Voleon Capital Management's AbCellera Biologics position peaked at $907K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.